Drug Type Small molecule drug |
Synonyms- |
Mechanism Akt stimulants(Proto-oncogene proteins c-akt stimulants), NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), PI3K family modulators(Phosphatidylinositol 3-kinase family modulators) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | IN | 01 Oct 2024 | |
Parkinson Disease | Preclinical | IN | 01 Oct 2024 |